Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Nusantara Sejahtera Raya Tbk. (CNMA) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Nusantara Sejahtera Raya Tbk.Trade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Nusantara Sejahtera Raya Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Nusantara Sejahtera Raya Tbk. trades at Rp95 (market cap 7.92T, 34.27M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp166 (market cap 651.75B, 722K 24h volume). The key difference: Nusantara Sejahtera Raya Tbk. is far larger — about 12.2× UBC Medical Indonesia Tbk.'s market cap, and Nusantara Sejahtera Raya Tbk. is more actively traded (34.27M versus 722K). Which is the better fit depends on your goals.

CNMALABS
Market Cap
7.92T651.75B
Volume
34.27M722K
Lot
342.67K7.22K
Turnover
3.22B119.4M
Average Price
94.03165.37
Value
3.22B119.4M
Indicative Equilibrium Price
95165
Indicative Equilibrium Volume
214.4K300

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

CNMA
View details
LABS
View details

About Nusantara Sejahtera Raya Tbk.

PT Nusantara Sejahtera Raya Tbk. (the “Company”) an Indonesian domiciled company, established on 7 June 1988 by deed of establishment No. 67, drawn up by Benny Kristianto, S.H. The Company commenced its commercial operations in 1989.

Read more on CNMA

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS